Cancer

EGFR tyrosine kinase inhibitors

Targeted drugs that block the epidermal growth factor receptor kinase; highly effective in lung adenocarcinomas carrying activating EGFR mutations, which is why tumours are tested before treatment.

Mechanism of action

Molecular targets

Drugs in EGFR tyrosine kinase inhibitors

First generation (reversible)

Second generation (irreversible)

Third generation

Therapeutic uses

Diseases it treats

Adverse effects

Contraindications by condition

Other cautions and interactions

Written from

Educational reference. Not medical advice, diagnosis or treatment.